Detroit Retains Depth on the Defensive Line
The Detroit Lions have opted to bring back defensive end Mitchell Agude, re-signing the 26-year-old for the 2025 NFL season. The move comes after a tumultuous 2024 campaign, during which injuries forced Detroit to shuffle its defensive front, providing Agude with an opportunity to contribute.
A Path Through Persistence
Agude’s journey to this moment has been anything but conventional. Originally entering the league as an undrafted free agent in 2023, he started his professional career with the Miami Dolphins but failed to make the final roster. He later found a place on Detroit’s practice squad, where he spent most of his rookie season.
Despite his practice-squad status, Agude stayed ready. When injuries decimated the Lions’ defensive line in 2024—sideling key players like Marcus Davenport, Alim McNeill, Aidan Hutchinson, John Cominsky, and Kyle Peko—Agude was called up to the active roster. Though his role was limited primarily to special teams, he made his presence felt, recording three tackles and forcing a fumble across four games.
Lions’ Decision on Agude’s Future
At the start of the offseason, Agude’s return was uncertain. Detroit had the opportunity to tender him an exclusive rights free agent contract but initially passed on the decision, leading to speculation about his future. However, the team ultimately decided to bring him back, reinforcing depth along the defensive front. Contract details were not immediately disclosed.
Shifting Focus in Free Agency
While securing Agude helps solidify depth, the Lions were rumored to be in the market for additional pass-rush help. One potential target, former Giants defensive end Azeez Ojulari, has since signed a one-year, $4 million contract with the Philadelphia Eagles. Though Detroit had familiarity with Ojulari from past joint practices with New York, concerns over his run defense may have deterred their pursuit.
With Agude back in the fold, the Lions continue to build their roster for 2025, balancing internal development with targeted acquisitions. If injuries strike again, Agude will be ready—just as he was in 2024.